168 related articles for article (PubMed ID: 7846282)
1. ATP sensitive potassium channels: potential drug targets in neuropsychopharmacology.
Gehlert DR; Robertson DW
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1093-102. PubMed ID: 7846282
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel openers as potential therapeutic weapons in ion channel disease.
Lawson K
Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
[TBL] [Abstract][Full Text] [Related]
3. New windows on the mechanism of action of K(ATP) channel openers.
Ashcroft FM; Gribble FM
Trends Pharmacol Sci; 2000 Nov; 21(11):439-45. PubMed ID: 11121575
[TBL] [Abstract][Full Text] [Related]
4. Is there a therapeutic future for "potassium channel openers'?
Lawson K
Clin Sci (Lond); 1996 Dec; 91(6):651-63. PubMed ID: 8976800
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosis.
Lahaye P; Fouassier L; Tazi KA; De Gottardi A; Fléjou JF; Chagneau C; Rona JP; Housset C; Reichen J; Lebrec D; Moreau R
J Hepatol; 1999 Jan; 30(1):107-14. PubMed ID: 9927157
[TBL] [Abstract][Full Text] [Related]
6. Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus.
Wasada T
Intern Med; 2002 Feb; 41(2):84-90. PubMed ID: 11868613
[TBL] [Abstract][Full Text] [Related]
7. Binding and effect of K ATP channel openers in the absence of Mg2+.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
[TBL] [Abstract][Full Text] [Related]
8. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
[TBL] [Abstract][Full Text] [Related]
9. Moving together: K+ channel openers and ATP-sensitive K+ channels.
Quast U; Cook NS
Trends Pharmacol Sci; 1989 Nov; 10(11):431-5. PubMed ID: 2692253
[No Abstract] [Full Text] [Related]
10. KATP channel openers: structure-activity relationships and therapeutic potential.
Mannhold R
Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
[TBL] [Abstract][Full Text] [Related]
11. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
12. Two different types of potassium channels in human skeletal muscle activated by potassium channel openers.
Quasthoff S; Franke C; Hatt H; Richter-Turtur M
Neurosci Lett; 1990 Nov; 119(2):191-4. PubMed ID: 2126363
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial K(ATP) channel and cardioprotection.
McCully JD; Levitsky S
Ann Thorac Surg; 2003 Feb; 75(2):S667-73. PubMed ID: 12607710
[TBL] [Abstract][Full Text] [Related]
14. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction.
Pollesello P; Mebazaa A
Curr Opin Crit Care; 2004 Dec; 10(6):436-41. PubMed ID: 15616383
[TBL] [Abstract][Full Text] [Related]
15. Contribution of both the sarcolemmal K(ATP) and mitochondrial K(ATP) channels to infarct size limitation by K(ATP) channel openers: differences from preconditioning in the role of sarcolemmal K(ATP) channels.
Tanno M; Miura T; Tsuchida A; Miki T; Nishino Y; Ohnuma Y; Shimamoto K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):226-32. PubMed ID: 11521165
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological functions of ATP-sensitive K+ channels in myocardial ischemia.
Hiraoka M
Jpn Heart J; 1997 May; 38(3):297-315. PubMed ID: 9290566
[TBL] [Abstract][Full Text] [Related]
17. Endogenous adenosine does not activate ATP-sensitive potassium channels in the hypoxic guinea pig ventricle in vivo.
Xu J; Wang L; Hurt CM; Pelleg A
Circulation; 1994 Mar; 89(3):1209-16. PubMed ID: 8124809
[TBL] [Abstract][Full Text] [Related]
18. The ATP-sensitive K+ channel.
Takano M; Noma A
Prog Neurobiol; 1993 Jul; 41(1):21-30. PubMed ID: 8321907
[TBL] [Abstract][Full Text] [Related]
19. ATP-sensitive K+ channel openers inhibit morphine withdrawal.
Robles LI; Barrios M; Baeyens JM
Eur J Pharmacol; 1994 Jan; 251(1):113-5. PubMed ID: 8137867
[TBL] [Abstract][Full Text] [Related]
20. Membrane ion channels and cardiovascular ATP-sensitive K+ channels.
Cavero I; Guillon JM
Cardiologia; 1993 Dec; 38(12 Suppl 1):445-52. PubMed ID: 7517343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
